SCHEMBL14795367

SCHEMBL14795367

COc1ccccc1Sc1cccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 17/20 0.54
PDGFRB P09619 12/20 0.54
KDR P35968 12/20 0.54
FLT1 P17948 8/20 0.54
CHEK1 O14757 3/20 0.54
DHFR P00374 1/20 0.49
AMY1A P0DUB6 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PLK4 O00444 1/20 0.43
STK25 O00506 1/20 0.43
CIT O14578 1/20 0.43
RIOK3 O14730 1/20 0.43
GAK O14976 1/20 0.43
CHUK O15111 1/20 0.43
MUSK O15146 1/20 0.43
EPHB6 O15197 1/20 0.43
PDPK1 O15530 1/20 0.43
MAP3K13 O43283 1/20 0.43
DAPK3 O43293 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3378283 0.88 FGFR1 (0.63) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14796196 0.86 FGFR1 (0.52) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3381700 0.77 FGFR1 (0.54) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL15911026 0.76 FGFR1 (0.67) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL1055142 0.76 FGFR1 (0.66) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL1052022 0.76 FGFR1 (0.66) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14796657 0.75 FGFR1 (0.62) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795940 0.75 FGFR1 (0.66) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3383658 0.75 FGFR1 (0.54) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795440 0.73 FGFR1 (0.54) FGFR1PDGFRBKDRFLT1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762475-A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use Novartis Vaccines and Diagnostics, Inc. (US) 2014-08-06 EP disclosed
EP-2573079-A2 Benzimidazole quinolinones and uses thereof Novartis Vaccines and Diagnostics, Inc. (US) 2013-03-27 EP disclosed